Janus Henderson Global Life Sciences Fund Class T (JAGLX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
82.72
+0.88 (1.08%)
At close: Feb 27, 2026
Fund Assets5.40B
Expense Ratio0.92%
Min. Investment$2,500
Turnover30.00%
Dividend (ttm)3.64
Dividend Yield4.45%
Dividend Growth-5.87%
Payout FrequencyAnnual
Ex-Dividend DateDec 5, 2025
Previous Close81.84
YTD Return2.83%
1-Year Return21.77%
5-Year Return48.95%
52-Week Low58.62
52-Week High82.93
Beta (5Y)0.63
Holdings104
Inception DateDec 31, 1998

About JAGLX

Janus Henderson Global Life Sciences Fund Class T is a mutual fund focused on the health sector, aiming to provide long-term capital growth. It invests primarily in companies with a life science orientation, seeking those that address unmet medical needs or enhance healthcare efficiency. The fund maintains a balanced portfolio across various sub-sectors, including biotechnology, healthcare services, medical devices, and pharmaceuticals. With a diversified approach across market capitalizations and geographies, it leverages the expertise of seasoned specialists to navigate the complex healthcare sector. By emphasizing growth potential and innovation, this fund plays a significant role in the financial market by capitalizing on advancements in healthcare technology and services.

Fund Family Janus Henderson
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol JAGLX
Share Class Class T
Index MSCI World/Health Care NR

Performance

JAGLX had a total return of 21.77% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.07%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
JFNNXClass N0.68%
JFNIXClass I0.77%
JNGLXClass D0.80%
JFNAXClass A0.98%

Top 10 Holdings

38.87% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY9.66%
Johnson & JohnsonJNJ5.59%
AstraZeneca PLCAZN4.27%
UnitedHealth Group IncorporatedUNH3.44%
AbbVie Inc.ABBV3.39%
Abbott LaboratoriesABT2.65%
argenx SEARGX2.63%
Novartis AG ADRNVSN.MX2.50%
Praxis Precision Medicines, Inc.PRAX2.39%
Boston Scientific CorporationBSX2.35%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 5, 2025$3.64134Dec 5, 2025
Dec 6, 2024$3.86839Dec 6, 2024
Dec 7, 2023$2.89991Dec 7, 2023
Dec 20, 2022$0.09366Dec 20, 2022
Dec 20, 2021$6.73381Dec 20, 2021
Dec 17, 2020$5.50316Dec 17, 2020
Full Dividend History